Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Prognostic Significance of Serum β 2 - Microglobulin Levels (sβ 2 m) in Diffuse Large B-Cell Lymphoma (DLBCL)

Blood (2024) 144 (Supplement 1): 6476.

https://doi.org/10.1182/blood-2024-210185

Published: 2024

Journal Articles

Disease Bulk and/or Very High LDH As Adverse Factors in IPI 1-2 Diffuse Large B-Cell Lymphoma (DLBCL): A Hellenic Database Validation of the LEO Cohort

Theodoros P. Vassilakopoulos, Maria Panagiota Arapaki, Christina Apostolopoulou, Evgenia Verrou, Christina H. Kalpadakis, Alexia Piperidou, Athanasios Liaskas, Sotirios Sachanas, Theodora Triantafyllou, Aikaterini Bitsani, Maria Dimou, Maria Anastasia Ioakeim, Marina Siakantaris, Gerassimos Pangalis, Eirini Katodritou, Maria Angelopoulou, Panayiotis Panayiotidis, Vassiliki Pappa, Sotirios G. Papageorgiou

Blood (2024) 144 (Supplement 1): 6362.

https://doi.org/10.1182/blood-2024-210585

Published: 2024

Journal Articles

Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Steroids (PolaRCHP) in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Real-Life Experience in Greece

Blood (2024) 144 (Supplement 1): 7767.

https://doi.org/10.1182/blood-2024-211525

Published: 2024

Journal Articles

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Blood (2022) 140 (Supplement 1): 12016–12017.

https://doi.org/10.1182/blood-2022-169972

Published: 2022

Journal Articles

Increased SERUM VON Willebrand Levels in Chronic Lymphocytic Leukemia (CLL) Patients Are Related to a Shorter Time to Treatment

Thommais Tryfou, MLS, Paraskevi Papaioannou, MD, Panagiotis Repousis, MD, Annita Ioanna Gkioka, MD, Sotirios Sachanas, Aikaterini Bitsani, MD, Maria Dimou, MD PhD, Dimitrios Maltezas, Aspasia Koudouna, MD, Anastasia Kopsaftopoulou, MD, Konstantina Chamoulkou, MD, Ioannis Grafakos, MD, Styliani Kokori, MD, Argyrios Tsantes, MD, Gerasimos Pangalis, MD, Panayiotis Panayiotidis, MD PhD, Marie-Christine Kyrtsonis, MD PhD

Blood (2018) 132 (Supplement 1): 5547.

https://doi.org/10.1182/blood-2018-99-119520

Published: 2018

Journal Articles

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Blood (2018) 132 (6): 666–670.

https://doi.org/10.1182/blood-2018-02-833608

Published: 2018

Journal Articles

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Blood (2014) 123 (8): 1199–1206.

https://doi.org/10.1182/blood-2013-07-515155

Published: 2014

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Nicoletta Kafasi, MD, Sotirios Sachanas, MD, Tatiana Tzenou, MD, Argiroula Papadogiannis, MD, Zacharoula Galanis, MD, Christina Kalpadakis, MD, Maria Dimou, MD, Elias Kyriakou, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 3522.

https://doi.org/10.1182/blood.V108.11.3522.3522

Published: 2006

Journal Articles

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Maria K. Angelopoulou, MD, Maria Papakonstantinou, MD, Flora N. Kontopidou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani Kokoris, MD, Evangelia M. Dimitriadou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Padelis Tsirkinidis, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4655.

https://doi.org/10.1182/blood.V108.11.4655.4655

Published: 2006

Journal Articles

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Sotirios Sachanas, Maria K. Angelopoulou, Konstantinos Anargyrou, Styliani I. Kokoris, Theodoros P. Vassilakopoulos, Zacharoula I. Galani, Evangelia M. Dimitriadou, Marina P. Siakantaris, Maria N. Dimopoulou, Flora N. Kontopidou, Marie-Christine Kyrtsonis, Eleni Plata, Panayiotis Tsaftaridis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4718.

https://doi.org/10.1182/blood.V108.11.4718.4718

Published: 2006

Journal Articles

Efficacy of Rituximab in Hairy Cell Leukemia.

Styliani I. Kokoris, Maria K. Angelopoulou, Zacharoula I. Galani, Konstantinos Anargyrou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Flora N. Kontopidou, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Panayiotis Tsaftaridis, Eleni Plata, Christina Kalpadakis, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4719.

https://doi.org/10.1182/blood.V108.11.4719.4719

Published: 2006

Journal Articles

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Blood (2006) 108 (11): 2745.

https://doi.org/10.1182/blood.V108.11.2745.2745

Published: 2006

Journal Articles

Z-Guggulsterone Downregulates Survivin and Induces Cell Death in Large B Cell Lymphoma Cells In Vitro.

Maria K. Angelopoulou, MD, Konstantinos Lilakos, Vassilios Salpeas, PhD, Sotirios Sachanas, MD, Penelope Korkolopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4752.

https://doi.org/10.1182/blood.V108.11.4752.4752

Published: 2006

Journal Articles

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Marie-Christine Kyrtsonis, MD, Sotirios Sachanas, MD, Theodoros P. Vassilakopoulos, MD, Nikoletta Kafassi, MD, Tatiana Tzenou, MD, Argyro Papadogiannis, MD, Christina Kalpadakis, MD, Antonios G. Antoniadis, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5193.

https://doi.org/10.1182/blood.V106.11.5193.5193

Published: 2005

Journal Articles

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Andreas Katsigiannis, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evridiki Michalis, MD, Evangelia M. Dimitriadou, MD, Marina P. Siakantaris, MD, Flora N. Kontopidou, MD, Christina Kalpadakis, MD, Angelos Sarantopoulos, MD, Pinelopi Korkolopoulou, MD, Paraskevi Roussou, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 935.

https://doi.org/10.1182/blood.V106.11.935.935

Published: 2005

Journal Articles

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Argyro Papadogiannis, MD, Marie-Cristine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Antonios G. Antoniadis, MD, Christina Kalpadakis, MD, Sotirios Sachanas, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos Pangalis, MD

Blood (2005) 106 (11): 5074.

https://doi.org/10.1182/blood.V106.11.5074.5074

Published: 2005

NARROW

The Prognostic Significance of Serum β 2 - Microglobulin Levels (sβ 2 m) in Diffuse Large B-Cell Lymphoma (DLBCL)

Disease Bulk and/or Very High LDH As Adverse Factors in IPI 1-2 Diffuse Large B-Cell Lymphoma (DLBCL): A Hellenic Database Validation of the LEO Cohort

Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Steroids (PolaRCHP) in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Real-Life Experience in Greece

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Increased SERUM VON Willebrand Levels in Chronic Lymphocytic Leukemia (CLL) Patients Are Related to a Shorter Time to Treatment

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Efficacy of Rituximab in Hairy Cell Leukemia.

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Z-Guggulsterone Downregulates Survivin and Induces Cell Death in Large B Cell Lymphoma Cells In Vitro.

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only